Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Looks to Auction Off Genomics-Related Items

NEW YORK, May 17 (GenomeWeb News) - As part of its ongoing transition from a genomics company to a pharmaceutical firm, Incyte hopes to auction off many of its genomic research and laboratory equipment, GenomeWeb News has learned.


DoveBid, a capital asset auction and valuation company, has reported on its website that it will hold a webcast auction of various Incyte assets deemed "surplus to [the company's] continuing operations."


Among the items up for sale are a Cytomation S-1312 MoFlo high performance cell sorter, centrifuges, ultracentrifuges, and automatic pipetors, said DoveBid.


The auction will be held on June 15 at 9 a.m. Pacific Daylight Time. Details about the event can be found at here.


The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.